NCT00249249

Study to Compare the Efficacy of Pitavastatin With That of Atorvastatin in Lowering Cholesterol Levels

Study of Pitavastatin 2 mg vs. Atorvastatin 10 mg and Pitavastatin 4 mg vs. Atorvastatin 20 mg (Following Up Titration) in Patients With Primary Hypercholesterolemia or Combined Dyslipidemia

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 830 (actual)
• Sponsor: Kowa Research Europe · Industry
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to compare the efficacy of pitavastatin with that of atorvastatin.

Detailed description

Following a wash-out dietary lead-in period, patients will receive either Atorvastatin or Pitavastatin during 12 weeks, in order to establish the efficacy of pitavastatin in reducing cholesterol levels.

Conditions

• Primary Hypercholesterolemia
• Dyslipidemia

Interventions

Type	Name	Description
DRUG	Pitavastatin
DRUG	Atorvastatin

Timeline

• Start date: 2005-10-01
• Completion: 2006-11-01
• First posted: 2005-11-07
• Last updated: 2010-01-12
• Results posted: 2009-12-16

Locations

192 sites across 13 countries: Denmark, Finland, Germany, India, Israel, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, United Kingdom